Technical Analysis for LBPH - Longboard Pharmaceuticals, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Up | Down | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
50 DMA Resistance | Bearish | 0.00% | |
Crossed Above 20 DMA | Bullish | 0.00% | |
MACD Bullish Signal Line Cross | Bullish | 0.00% | |
Bollinger Band Squeeze | Range Contraction | 0.00% | |
BB Squeeze Started | Range Contraction | 0.00% | |
Gapped Up | Strength | 0.00% | |
20 DMA Resistance | Bearish | 4.33% | |
NR7 | Range Contraction | 4.33% | |
Narrow Range Bar | Range Contraction | 4.33% | |
Multiple of Ten Bullish | Other | 4.33% |
Alert | Time |
---|---|
50 DMA Resistance | about 17 hours ago |
Up 1 ATR | about 19 hours ago |
Rose Above 50 DMA | about 19 hours ago |
Up 5% | about 20 hours ago |
20 DMA Support | about 20 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/07/2024
Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing medicines for neurological diseases. Its products include LP352, a Phase I clinical trial product for the developmental and epileptic encephalopathies (DEEs) and refractory epilepsies; LP143, a product for amyotrophic lateral sclerosis and other neuroinflammatory disorders; and LP659, a product for multiple neuroinflammatory disorders. Longboard Pharmaceuticals, Inc. was formerly known as Arena Neuroscience, Inc. and changed its name to Longboard Pharmaceuticals, Inc. in October 2020. The company was founded in 2020 and is based in San Diego, California.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Biology Neuroscience Epilepsy Psychiatry Neurophysiology Amyotrophic Lateral Sclerosis Neurology Nervous System Clinical Trial Product Neurological Diseases
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Biology Neuroscience Epilepsy Psychiatry Neurophysiology Amyotrophic Lateral Sclerosis Neurology Nervous System Clinical Trial Product Neurological Diseases
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 28.15 |
52 Week Low | 3.6 |
Average Volume | 661,708 |
200-Day Moving Average | 10.70 |
50-Day Moving Average | 21.42 |
20-Day Moving Average | 20.25 |
10-Day Moving Average | 20.07 |
Average True Range | 1.52 |
RSI (14) | 53.92 |
ADX | 11.2 |
+DI | 23.62 |
-DI | 17.10 |
Chandelier Exit (Long, 3 ATRs) | 19.95 |
Chandelier Exit (Short, 3 ATRs) | 22.64 |
Upper Bollinger Bands | 21.85 |
Lower Bollinger Band | 18.66 |
Percent B (%b) | 0.73 |
BandWidth | 15.73 |
MACD Line | -0.14 |
MACD Signal Line | -0.19 |
MACD Histogram | 0.0489 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 23.13 | ||||
Resistance 3 (R3) | 23.13 | 22.41 | 22.77 | ||
Resistance 2 (R2) | 22.41 | 21.86 | 22.41 | 22.65 | |
Resistance 1 (R1) | 21.70 | 21.52 | 22.05 | 21.70 | 22.53 |
Pivot Point | 20.98 | 20.98 | 21.15 | 20.98 | 20.98 |
Support 1 (S1) | 20.26 | 20.43 | 20.62 | 20.26 | 19.43 |
Support 2 (S2) | 19.54 | 20.09 | 19.54 | 19.31 | |
Support 3 (S3) | 18.83 | 19.54 | 19.19 | ||
Support 4 (S4) | 18.83 |